Latest California Healthline Stories
States Looking To Tax Opioids Pin Hopes On November Elections
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
Rudy Giuliani’s Consulting Firm Had Hand In Halting Florida’s Opioid Investigation
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Podcast: KHN’s ‘What The Health?’ Ask Us Anything!
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico answer listeners’ questions about health policy and politics.
CalPERS Health Chief Wields The Power Of Data To Tame Costs
Liana Bailey-Crimmins brings her information-technology expertise to CalPERS’ health division, aiming to curtail spending on otherwise costly procedures and drugs.
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Clinicians Who Learn Of A Patient’s Opioid Death Modestly Cut Back On Prescriptions
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
Key California Lawmaker Calls Eli Lilly’s Behavior ‘Disingenuous And Offensive’
Sen. Ed Hernandez is in a public spat with the Indianapolis drugmaker over the company’s refusal to heed a state law requiring advance notice — and justification — of large drug price hikes. The company says it is awaiting a court decision on the law’s constitutionality.
Medicaid Expansion Making Diabetes Meds More Accessible To Poor, Study Shows
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
Expansión de Medicaid facilita el acceso de los más pobres a drogas anti diabetes
El estudio revela que las recetas para drogas contra la diabetes aumentaron un 40% en los estados que expandieron Medicaid bajo ACA. También lo hicieron los diagnósticos.